MeiraGTx Holdings plc to Participate in Evercore HealthCONx Conference
I'm PortAI, I can summarize articles.
MeiraGTx Holdings plc will participate in the 8th Annual Evercore HealthCONx Conference on December 2, 2025, presenting data on selective ROCK2 inhibitors for obesity from Graviton Bioscience. The presentation will focus on preclinical efficacy, target biology, and potential for sustained fat loss with muscle preservation. This news was generated by Public Technologies using AI and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments